Demiana Faltaos

Demiana Faltaos is the Vice President and Head of Clinical Pharmacology at Olema Oncology, a position she has held since November 2020. She is based in the San Francisco Bay Area and has a robust background in clinical pharmacology, particularly within oncology drug development.

Professional Experience

• Olema Oncology (2020 - Present)
  • Vice President, Head of Clinical Pharmacology
• Mirati Therapeutics (2014 - 2020)
  • Head of Clinical Pharmacology
• Amylin Pharmaceuticals (2011 - 2014)
  • Senior Investigator in Pharmacometrics
• FDA (2009 - 2011)
  • Research Fellow in the Division of Pharmacometrics
• Johnson & Johnson (2007 - 2009)
  • PK/PD Scientist
• INSERM (2003 - 2007)
  • Clinical Research Associate and Clinical Project Leader

Education

Demiana holds multiple degrees in pharmacology:

• PhD in Clinical Pharmacology from Université Paris Cité (2002 - 2006)
• Master’s Degree in Pharmacokinetics and Drug Metabolism from Paris-Sud University (2003 - 2004)
• Master’s Degree in Clinical Pharmacology from Université Henri Poincaré, Nancy 1 (2001 - 2002)

Skills and Languages

She is multilingual, fluent in French, German, Arabic, and has elementary proficiency in Spanish. Her expertise encompasses a deep understanding of oncology drug development processes and pharmacometric modeling.

Demiana Faltaos's professional journey reflects a strong commitment to advancing clinical pharmacology within the oncology field, leveraging her extensive experience to contribute to drug development strategies at Olema Oncology.